As a consequence of AKI, a significant number of oxygen free radicals are produced, endogenous antioxidants are continually depleted, and high levels of inflammatory substances are secreted, all of which contribute to kidney damage progression ( According to our published papers (Zhou et al., 2021)
ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS Foundayo is the second oral GLP-1 drug approved for weight management Straight Healthcare April 2026 April 2026 The FDA recently approved Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in adults
There is some evidence to suggest that glutathione may be beneficial for people with Parkinsons disease
Personalized GIP + GLP-1 targets two pathways (GIP and GLP-1), which can provide broader metabolic support for some people
When you join our program, you get more than just access to medication shipped from high-quality compounding pharmacies